Laddar...
Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine
Background. We estimated the potential impact and cost-effectiveness of providing 3-doses of nonavalent human papillomavirus (HPV) vaccine (9vHPV) to females aged 13–18 years who had previously completed a series of quadrivalent HPV vaccine (4vHPV), a strategy we refer to as “additional 9vHPV vaccin...
Sparad:
| I publikationen: | J Infect Dis |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4857476/ https://ncbi.nlm.nih.gov/pubmed/26908738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw046 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|